Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Current at Least Moderately Severe Anxiety and Lifetime Panic Disorder or Generalized Anxiety Disorder
NCT00167479 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Current at Least Moderately Severe Anxiety and Lifetime Panic Disorder or Generalized Anxiety Disorder
- Lead sponsor
- University of South Florida
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2003
- Completion date
- September 30, 2006
- Enrollment
- 60
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.